Postoperative Glycemic Variability as a Predictor of Adverse Outcomes Following Lumbar Fusion

医学 血糖性 不利影响 优势比 腰椎 回顾性队列研究 内科学 外科 胰岛素
作者
José A. Canseco,Michael P. Chang,Brian A. Karamian,Kristen J. Nicholson,Parthik D. Patel,Kartik Shenoy,Joe Hartman,Mark F. Kurd,Jeffrey A. Rihn,David Greg Anderson,Alan S. Hilibrand,Christopher K. Kepler,Alexander Richard Vaccaro,Gregory Douglas Schroeder
出处
期刊:Spine [Lippincott Williams & Wilkins]
卷期号:47 (7): E304-E311 被引量:18
标识
DOI:10.1097/brs.0000000000004214
摘要

STUDY DESIGN: A retrospective cross-sectional study. OBJECTIVE: This study aims to evaluate the effect size of postoperative glycemic variability on surgical outcomes among patients who have undergone one- to three-level lumbar fusion. SUMMARY OF BACKGROUND DATA: While numerous patient characteristics have been associated with surgical outcomes after lumbar fusion, recent studies have described the measuring of postoperative glycemic variability as another promising marker. METHODS: A total of 850 patients were stratified into tertiles (low, moderate, high) based on degree of postoperative glycemic variability defined by coefficient of variation (CV). Surgical site infections were determined via chart review based on the Centers for Disease Control and Prevention definition. Demographic factors, surgical characteristics, inpatient complications, readmissions, and reoperations were determined by chart review and telephone encounters. RESULTS: Overall, a statistically significant difference in 90-day adverse outcomes was observed when stratified by postoperative glycemic variability. In particular, patients with high CV had a higher odds ratio (OR) of readmission (OR = 2.19 [1.17, 4.09]; P = 0.01), experiencing a surgical site infection (OR = 3.22 [1.39, 7.45]; P = 0.01), and undergoing reoperations (OR = 2.65 [1.34, 5.23]; P = 0.01) compared with patients with low CV. No significant association was seen between low and moderate CV groups. Higher CV patients were more likely to experience longer hospital stays (β: 1.03; P = 0.01). Among the three groups, high CV group experienced the highest proportion of complications. CONCLUSION: Our study establishes a significant relationship between postoperative glycemic variability and inpatient complications, length of stay, and 90-day adverse outcomes. While HbA1c has classically been used as the principal marker to assess blood glucose control, our results show CV to be a strong predictor of postoperative adverse outcomes. Future high-quality, prospective studies are necessary to explore the true effect of CV, as well as its practicality in clinical practice. Nevertheless, fluctuations in blood glucose levels during the inpatient stay should be limited to improve patient results.Level of Evidence: 4.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
wangwang完成签到,获得积分20
1秒前
完美世界的应助被开朗的尔蝶采纳,获得10
1秒前
1秒前
高贵冰烟完成签到,获得积分10
1秒前
坏坏完成签到,获得积分10
2秒前
飞翔的完成签到,获得积分10
2秒前
hhh发布了新的文献求助30
2秒前
llee2005完成签到,获得积分10
3秒前
3秒前
名古邬发布了新的文献求助20
4秒前
阿猫发布了新的文献求助10
5秒前
fantasy的应助被kbyang采纳,获得10
5秒前
EmmmlXL完成签到 ,获得积分10
6秒前
6秒前
锖青发布了新的文献求助10
7秒前
cpm完成签到,获得积分10
7秒前
aaaamy完成签到,获得积分10
7秒前
7秒前
好眠哈密瓜完成签到 ,获得积分10
8秒前
今后的应助被冰棍采纳,获得10
8秒前
8秒前
wangyi完成签到,获得积分10
9秒前
长庚完成签到,获得积分10
9秒前
Mythic完成签到,获得积分10
10秒前
怕孤独的飞飞完成签到,获得积分10
10秒前
义气的银耳汤完成签到 ,获得积分10
11秒前
11秒前
wanci的应助被wlj采纳,获得10
11秒前
永恒完成签到 ,获得积分10
12秒前
12秒前
www发布了新的文献求助10
12秒前
13秒前
14秒前
共享精神的应助被SHL采纳,获得10
15秒前
Zzz完成签到,获得积分10
15秒前
JINYUBAO完成签到,获得积分10
15秒前
tianjing0307完成签到 ,获得积分10
16秒前
枫楠完成签到,获得积分10
16秒前
16秒前
斯文败类的应助被风中的宛白采纳,获得10
17秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Boundaries and Bodhisattvas 500
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8181460
求助须知:如何正确求助?哪些是违规求助? 9571362
关于积分的说明 21817839
捐赠科研通 7777938
什么是DOI,文献DOI怎么找? 3433494
关于科研通互助平台的介绍 2557696
邀请新用户注册赠送积分活动 2479550